Visus Therapeutics to Attend TD Cowen’s 43rd Annual Health Care Conference

Visus Therapeutics Inc., a clinical-stage biopharmaceutical company focused on developing multi-targeted ophthalmic therapies for the front and back of the eye, today announced that Ben Bergo, Co-Founder and Chief Executive Officer, TD Cowen, 43 Will participate in th Annual Healthcare Conference. March 6-8, 2023 in Boston. Mr. Burgo will also be available for one-on-one meetings … Read more

OpenAI shifts from AGI talk to ChatGPT API release, as developers cheer

OpenAI shifts from AGI talk to ChatGPT API release, as developers cheer

Just three months after launching tech-generating superstar ChatGPT, and just days after releasing a blog post about its “plans” for artificial general intelligence (AGI), OpenAI yesterday released its ChatGPT and Whisper APIs. issued. APIs make it easy to integrate ChatGPT into different applications. According to the blog post, the APIs give developers “access to advanced … Read more

Neural Propulsion Systems Secures Series B Strategic Investment from Raytheon Technologies

Neural Propulsion Systems (NPS), a pioneer in hyper-resolution digital imaging radar technology, today announced a new Series B strategic investment by RTX Ventures, the venture capital arm of Raytheon Technologies (NYSE: RTX). The funding will help NPS develop next-generation radar technology capable of providing 10 times better resolution and 2.5 times greater range for mobility … Read more